Please assess the completion status of the following clinical trial:

Trial Title: Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~1. Males and females between 18 and 60 years of age.~2. History of grass and/or ragweed allergic rhinitis.~3. Positive skin or RAST test to grass, trees and/or ragweed antigen.~4. Symptomatic at time of entry into study.~Exclusion Criteria~1. Women of childbearing potential not using the contraception method(s) (Birth control pills, depo Provera, double barrier) as well as women who are pregnant or breastfeeding.~2. Patients with severe medical condition(s) that in the view of the investigator prohibits participation in the study (heart, lung, kidney, neurological, oncologic or liver disease).~3. Use of any other investigational agent in the last 30 days.~4. Absence of nasal symptoms.~5. Smoking.~6. URI at the time of screening.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): 2 weeks of treatment
- 2 (Type: PLACEBO_COMPARATOR): 2 weeks of treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).